Updated on 18 June 2013
To undergo screening, a customer needs to register with Jai Health and receive a Jai Health kit with a buccal (mouth) swab, a simple, quick, non-invasive and painless way to collect a sample of person's DNA. The sample is returned to Jai Health in a prepaid envelope and within four weeks. Jai Health, after carrying out the tests, informs the patient of any genetic risk related to heart disease which can develop in the next 10 years.
"JaiHeart can give a signal of risk long before heart disease becomes symptomatic. This will help patients and doctor initiate the necessary lifestyle changes, further investigations and medical interventions to reduce the risk of a heart attack," said Mr Sanjay Kakkar, chairman and founder, Jai Health. The test kit has its possible applications in heart disease, diabetes and other chronic diseases.
Gene delivery vehicle
Singapore-based Anovasia has developed technology called 'molecular painting' to facilitate genetic diagnostic for several diseases. Molecular painting can be applied in the research lab or developed as a tool for improving vaccines; in purifying and isolating viruses and micro-vesicles; and in targeting and increasing transduction of viral gene delivery vehicles.
In diagnostics, molecular painting reagents can be mixed into clinical or biological samples to tag, isolate (concentrate/purify), detect and quantify viruses, which cause infection; or tag exosomes that may signal a certain disease status. In vaccine development, molecular painting reagents can be used for immunomodulation purposes by signaling and targeting vaccine agents to specific immune cell types that are better able to give an immune response, such as dendritic cells and other antigen presenting cells. In the domain of gene therapy, MP reagents can be used to direct or re-direct the pathway of entry for the gene delivery vehicle to a chosen target cell.